3079 — DVx Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeMicro CapNeutral

Annual income statement for DVx, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	41,007	45,496	47,484	45,851	50,322
Cost of Revenue
Gross Profit	4,957	5,336	5,456	4,765	4,994
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	40,165	44,244	46,146	45,485	49,791
Operating Profit	842	1,252	1,337	366	531
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	845	1,259	1,351	376	538
Provision for Income Taxes
Net Income After Taxes	572	863	936	173	410
Net Income Before Extraordinary Items
Net Income	572	863	936	173	410
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	572	863	936	173	410
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	55.8	83.3	90.2	29.4	39.6
Dividends per Share